Liminatus Pharma (LIMN) Short term Debt (2024 - 2026)
Liminatus Pharma (LIMN) posted Short term Debt of $1.4 million for Q1 2026, little changed sequentially from $1.4 million in Q4 2025, and up 596.86% YoY from $207000.0 in Q1 2025.
Liminatus Pharma (LIMN) Short term Debt (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Short term Debt for 3 years, with the latest figure at $1.4 million in Q1 2026.
- Quarterly Short term Debt rose 596.86% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 596.86% YoY) and the FY2025 annual result came in at $1.4 million, down 92.78% from the prior year.
- Short term Debt held at $1.4 million in Q1 2026 per LIMN's latest filing, from $1.4 million in the prior quarter.
- Over five years, Short term Debt peaked at $20.0 million in Q4 2024 and troughed at $207000.0 in Q1 2025.
- A 3-year average of $3.9 million and a median of $1.4 million in 2025 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2025 and 2026: Short term Debt tumbled 92.78% in 2025, then soared 596.86% in 2026.
- Over 3 years, Short term Debt stood at $20.0 million in 2024, then sank by 92.78% to $1.4 million in 2025, then changed by 0.0% to $1.4 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $1.4 million, $1.4 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Liminatus Pharma | 258.93 Mn | 258.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.44 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 207,000.00 |
| Dec 31, 2024 | 19.97 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | 2.80 Mn |